SILVER SPRING, Md.--(BUSINESS WIRE)--AnthroTronix and Cambridge Cognition Holdings PLC (Cambridge, UK – LSE: COG), have signed a distribution agreement to sell DANATM, AnthroTronix’s FDA-cleared mobile brain health assessment app, to markets in the U.S. and Europe. In the U.S., Cambridge Cognition will distribute DANA for use in academic research, clinical trials, and pharmaceutical development. In the United Kingdom and portions of Europe, DANA will be marketed for use in militaries, academic
![]()
↧